Search Results - Timothy Hanlon

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer by Kasia M. Dillon, Raie T. Bekele, Zsofia Sztupinszki, Timothy Hanlon, Shahrzad Rafiei, Zoltan Szallasi, Atish D. Choudhury, Kent W. Mouw

    Published in npj Precision Oncology (2022-06-01)
    Get full text
    Article


  2. 2

    Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma by Aurel Prosz, Haohui Duan, Viktoria Tisza, Pranshu Sahgal, Sabine Topka, Gregory T. Klus, Judit Börcsök, Zsofia Sztupinszki, Timothy Hanlon, Miklos Diossy, Laura Vizkeleti, Dag Rune Stormoen, Istvan Csabai, Helle Pappot, Joseph Vijai, Kenneth Offit, Thomas Ried, Nilay Sethi, Kent W. Mouw, Sandor Spisak, Shailja Pathania, Zoltan Szallasi

    Published in Scientific Reports (2023-11-01)
    Get full text
    Article


Search Tools: